Kidswell And Chiome Team Up On Biosimilar Development
The Companies See Biosimilars As An Underused Opportunity In Japan
In an effort to set themselves apart from other Japanese companies, Kidswell and Chiome have signed a deal focused on the co-development of new biosimilars and profit sharing.
